CardiAMP treats ischemic heart failure
BioCardia tests CardiAMP, an autologous mononuclear cell therapy delivered via minimally invasive catheter. The platform uses the Helix system for precise tissue delivery to treat ischemic heart failure.
- Field
- gene therapy
- What they did
- BioCardia is developing a therapy using the patient's own cells to treat heart failure, delivering them via minimally invasive catheter procedures.
- Why it matters
- This could help people with ischemic heart failure who lack other effective treatment options.
#cell therapy#heart failure#biocardia#cardiamp#regenerative medicine



